SHENZHEN, China, Aug. 27 /PRNewswire-Asia/ -- On August 10, 2009, Winner Medical Group Inc. (OTC Bulletin Board: WMDG; "Winner Medical", or the "Company") entered into a contract with a machine producer in China to purchase a new production line for its PurCotton products.
This new machineries will constitute the fourth production line of PurCotton products, and will be installed and operated in the Company’s subsidiary in Huanggang, and it is expected to start production in the second quarter of 2010.
Mr. Jianquan Li, Chief Executive Officer, commented, "The recognition of top-tier clients to the premium quality of our PurCotton products leads to an increasing market demand. Currently, orders from our clients in China, the United States, Japan, and other countries reached approximately 150 tonnes per month; and it is expected to increase in the future. The new production line will increase our production capacity of PurCotton products so as to meet the increasing demand."
"As we have gained more experience after installing the first two lines, we believe the production capacity of the fourth production line will be much higher than the first or the second production line, though they are similar in nature and are all produced in China."
"This innovative, technologically-enhanced fabric offers significant advantages to synthetic nonwoven products, for instance, it is more eco-friendly, with greater absorbency and higher tensile strength. Furthermore, our patented advanced automation and design process, which is obtained in China, the United States, Russia, Singapore, South Africa, and 34 member states of the European Patent Office, reduces the average cycle time for production of the finished cloth from raw materials. We will continue to develop the market demand for PurCotton while expanding the production accordingly, and we believe PurCotton will give Winner Medical a strong competitive edge in the global marketplace," Mr. Li concluded.
About Winner Medical
Winner Medical is a leading manufacturer in the medical dressing industry (medical and wound care products) in China. Headquartered in Shenzhen, the Company has seven wholly owned manufacturing and distribution facilities, four joint-venture factories and over 5,000 employees. The Company engages in the manufacture, sale, research, and development of medical care products, wound care products, home care products and PurCotton products, a nonwoven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the United States and Japan serving as the top three markets. The Company currently holds 50 patents and patent applications for various products and manufacturing processes and is one of the few Chinese companies licensed by the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the United States market. To learn more about Winner Medical, visit Winner Medical’s web site http://www.winnermedical.com .
Forward-Looking Statements
This press release contains certain statements that may include "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies’ business strategy, plans and objective and statements of non-historical information. These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical’s periodic reports that are filed with and available from the Securities and Exchange Commission. All forward- looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.
For more information, please contact:
Investor Relations Contacts:
Peng Zhai
Assistant Manager, Investor Relations
Winner Medical Group Inc.
Tel: +86-755-2806-6858
Email: investors@winnermedical.com
